{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:59Z","timestamp":1756902179876,"version":"3.44.0"},"reference-count":20,"publisher":"The Pediatric Pharmacy Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"abstract":"<jats:p>Cornelia de Lange Syndrome is a rare genetic disorder that results in distinctive craniofacial deformities, developmental delay, hirsutism, and other physical abnormalities. Case reports suggest some of these patients exhibit sensitivity and paradoxical reactions to certain psychoactive drugs. This report of a 16-year-old male with Cornelia de Lange is the first to describe dystonia from a first-generation antipsychotic that did not respond to conventional treatment with diphenhydramine. The patient initially presented to the Emergency Department for agitation, which progressively worsened after administration of diphenhydramine, olanzapine, and intramuscular haloperidol. The patient returned to the Emergency Department the following day because of altered mental status and lethargy that progressed to periodic lip-smacking movements and contraction of his upper extremities. His symptoms continued despite administration of diphenhydramine and loading doses of 3 antiepileptic drugs. His abnormal labs included an elevated creatine kinase and a prolonged QTc interval on his electrocardiogram. His symptoms were later deemed a probable drug-induced dystonic reaction to haloperidol once seizures were excluded by an unremarkable electroencephalogram. This case supports previous reports suggesting an association between Cornelia de Lange and paradoxical drug reactions, and it is recommended that clinicians strongly weigh the risks of prescribing first-generation antipsychotics for this patient population. These medications should be carefully titrated, with close patient monitoring to prevent adverse drug effects and other iatrogenic complications because antidotes may be rendered ineffective by this condition.<\/jats:p>","DOI":"10.5863\/1551-6776-24.2.160","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T18:31:02Z","timestamp":1555957862000},"page":"160-165","source":"Crossref","is-referenced-by-count":0,"title":["Diphenhydramine-Refractory Antipsychotic-Induced Dystonia in an Adolescent Male With Cornelia de Lange Syndrome"],"prefix":"10.5863","volume":"24","author":[{"given":"Stephen M.","family":"Small","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel S.","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"4","key":"i1551-6776-24-2-160-b1","series-title":"Clin Genet","first-page":"303","article-title":"Cornelia de Lange syndrome, cohesin, and beyond","volume":"76","year":"2009","unstructured":"Liu\n              J\n            , KrantzID.\n          Cornelia de Lange syndrome, cohesin, and beyond. Clin Genet. 2009;76(4):303\u2013314."},{"key":"i1551-6776-24-2-160-b2","series-title":"Ann N Y Acad Sci","first-page":"22","article-title":"On the molecular etiology of Cornelia de Lange syndrome","volume":"1151","year":"2009","unstructured":"Dorsett\n              D\n            , KrantzID.\n          On the molecular etiology of Cornelia de Lange syndrome. Ann N Y Acad Sci. 2009;1151:22\u201337."},{"key":"i1551-6776-24-2-160-b3","series-title":"Neuropsychiatry and Behavioral Pharmacology","first-page":"173","article-title":"Behavior in the Cornelia de Lange Syndrome","year":"1991","unstructured":"Gaultieri\n              CT.\n            \n          \n          Behavior in the Cornelia de Lange Syndrome. In: Neuropsychiatry and Behavioral Pharmacology. New York, NY: Springer-Verlag; 1991:173\u2013186."},{"issue":"6","key":"i1551-6776-24-2-160-b4","series-title":"Anesthesiology","first-page":"1162","article-title":"Anesthetic management of a patient with Cornelia de Lange Syndrome","volume":"74","year":"1991","unstructured":"Sargent\n              WW.\n            \n          \n          Anesthetic management of a patient with Cornelia de Lange Syndrome. Anesthesiology. 1991;74(6):1162\u20131163."},{"issue":"9","key":"i1551-6776-24-2-160-b5","series-title":"Anaesthesia","first-page":"924","article-title":"Cornelia de Lange syndrome, hyperthermia and a difficult airway","volume":"58","year":"2003","unstructured":"Papadimos\n              TJ\n            , MarcoAP.\n          Cornelia de Lange syndrome, hyperthermia and a difficult airway. Anaesthesia. 2003;58(9):924\u2013925."},{"issue":"1","key":"i1551-6776-24-2-160-b6","series-title":"Int J Clin Pharm","first-page":"1","article-title":"Unpredictable drug reaction in a child with Cornelia de Lange Syndrome","volume":"37","year":"2015","unstructured":"Stevic\n              M\n            , MilojevicI, BokunZ, SimicD.\n          Unpredictable drug reaction in a child with Cornelia de Lange Syndrome. Int J Clin Pharm. 2015;37(1):1\u20133."},{"issue":"4","key":"i1551-6776-24-2-160-b7","series-title":"Anaesthesia","first-page":"324","article-title":"Respiratory arrest after a caudal injection of bupivacaine","volume":"44","year":"1989","unstructured":"Lumb\n              AB\n            , CarliF.\n          Respiratory arrest after a caudal injection of bupivacaine. Anaesthesia. 1989;44(4):324\u2013325."},{"issue":"5","key":"i1551-6776-24-2-160-b8","series-title":"Clin Genet","first-page":"343","article-title":"The de Lange syndrome: report of 15 cases","volume":"35","year":"1989","unstructured":"Filippi\n              G.\n            \n          \n          The de Lange syndrome: report of 15 cases. Clin Genet. 1989;35(5):343\u2013363."},{"issue":"7210","key":"i1551-6776-24-2-160-b9","series-title":"BMJ","first-page":"623","article-title":"Acute dystonia induced by drug treatment","volume":"319","year":"1999","unstructured":"Van Harten\n              PN\n            , HoekHW, KahnRS.\n          Acute dystonia induced by drug treatment. BMJ. 1999;319(7210):623\u2013626."},{"issue":"1","key":"i1551-6776-24-2-160-b10","series-title":"Neurol Clin","first-page":"127","article-title":"Movement disorders induced by antipsychotic drugs: implications of the CATIE Schizophrenia Trial","volume":"29","year":"2011","unstructured":"Caroff\n              SN\n            , HurfordI, LybrandJ, CampbellEC.\n          Movement disorders induced by antipsychotic drugs: implications of the CATIE Schizophrenia Trial. Neurol Clin. 2011;29(1):127\u2013148."},{"issue":"3","key":"i1551-6776-24-2-160-b11","series-title":"Psychiatry (Edgmont)","first-page":"36","article-title":"Antipsychotic-induced movement disorders: evaluation and treatment","volume":"2","year":"2005","unstructured":"Mathews\n              M\n            , GratzS, AdetunjiB, \n          et al. Antipsychotic-induced movement disorders: evaluation and treatment. Psychiatry (Edgmont). 2005;2(3):36\u201341."},{"issue":"6","key":"i1551-6776-24-2-160-b12","series-title":"Clin Pharmacokinet","first-page":"435","article-title":"Pharmacokinetics of haloperidol: an update","volume":"37","year":"1999","unstructured":"Kudo\n              S\n            , IshizakiT.\n          Pharmacokinetics of haloperidol: an update. Clin Pharmacokinet. 1999;37(6):435\u2013456."},{"key":"i1551-6776-24-2-160-b13","series-title":"Clin Pharmacol Ther","first-page":"239","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","year":"1981","unstructured":"Naranjo\n              CA\n            , BustoU, SellersEM, \n          et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u2013245."},{"key":"i1551-6776-24-2-160-b14","series-title":"BMJ Case Reports","article-title":"Medication-induced acute dystonic reaction: the challenge of diagnosing movement disorders in the intensive care unit","volume":"2015","year":"2015","unstructured":"Digby\n              G\n            , JaliniS, TaylorS.\n          Medication-induced acute dystonic reaction: the challenge of diagnosing movement disorders in the intensive care unit. BMJ Case Reports. 2015;2015:bcr2014207215."},{"issue":"3","key":"i1551-6776-24-2-160-b15","series-title":"Am J Med Genet C Semin Med Genet","first-page":"248","article-title":"Natural history of aging in Cornelia de Lange syndrome","volume":"145C","year":"2007","unstructured":"Kline\n              AD\n            , GradosM, SponsellerP, \n          et al. Natural history of aging in Cornelia de Lange syndrome. Am J Med Genet C Semin Med Genet. 2007;145C(3):248\u2013260."},{"year":"2015","series-title":"Pharmacotherapy in CdLS","key":"i1551-6776-24-2-160-b16","unstructured":"Grados\n              M\n            , SrivastavaS.\n          Pharmacotherapy in CdLS. Avon, CT: Cornelia de Lange Syndrome Foundation Inc; 2015."},{"issue":"11","key":"i1551-6776-24-2-160-b17","series-title":"US Pharm","first-page":"HS16","article-title":"Drug-induced movement disorders: a primer","volume":"32","year":"2007","unstructured":"Chen\n              JJ.\n            \n          \n          Drug-induced movement disorders: a primer. US Pharm. 2007;32(11):HS16\u2013HS32"},{"issue":"9","key":"i1551-6776-24-2-160-b18","series-title":"Paediatr Child Health","first-page":"590","article-title":"Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth","volume":"16","year":"2011","unstructured":"Pringsheim\n              T\n            , DojaA, BelangerS, \n          et al. Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth. Paediatr Child Health. 2011;16(9):590\u2013598."},{"issue":"2","key":"i1551-6776-24-2-160-b19","series-title":"Emerg Med J","first-page":"130","article-title":"Drug-induced movement disorders in children at paediatric emergency department: \u2018dystonia\u2019","volume":"30","year":"2013","unstructured":"Derinoz\n              O\n            , CaglarAA.\n          Drug-induced movement disorders in children at paediatric emergency department: \u2018dystonia\u2019. Emerg Med J. 2013;30(2):130\u2013133."},{"issue":"3","key":"i1551-6776-24-2-160-b20","series-title":"Clin Exp Emerg Med","first-page":"133","article-title":"Clinical characteristics of acute drug-induced dystonia in pediatric patients","volume":"4","year":"2017","unstructured":"Park\n              HW\n            , KwakJR, LeeJS.\n          Clinical characteristics of acute drug-induced dystonia in pediatric patients. Clin Exp Emerg Med. 2017;4(3):133\u2013137."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/24\/2\/article-p160.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/24\/2\/160\/2466915\/1551-6776-24_2_160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/24\/2\/article-p160.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/24\/2\/article-p160.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:41:23Z","timestamp":1747356083000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/24\/2\/article-p160.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":20,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-24.2.160","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2019]]}}}